Why ImmunityBio (IBRX) Is Surging Today
ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an “alternative source ...
Why ImmunityBio, Inc. (IBRX) Went Up On Wednesday?
We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...
Insider Monkey4d
Why ImmunityBio (IBRX) Is Surging Today
ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an “alternative source of BCG.” Specifically, the company will now be able to provide this ...
ImmunityBio’s (IBRX) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital restated their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a report released on Friday,Benzinga reports. They currently have a $30.00 price target on the stock.
FDA authorizes ImmunityBio to provide rBCG to urologists amid shortages
ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins
Detailed price information for Immunitybio Inc (IBRX-Q) from The Globe and Mail including charting and trades.